Nutra Pharma's market value is the price at which a share of Nutra Pharma trades on a public exchange. It measures the collective expectations of Nutra Pharma Corp investors about its performance. Nutra Pharma is trading at 1.0E-4 as of the 3rd of March 2026, a No Change since the beginning of the trading day. The stock's open price was 1.0E-4. With this module, you can estimate the performance of a buy and hold strategy of Nutra Pharma Corp and determine expected loss or profit from investing in Nutra Pharma over a given investment horizon. Check out Nutra Pharma Correlation, Nutra Pharma Volatility and Nutra Pharma Performance module to complement your research on Nutra Pharma.
It's important to distinguish between Nutra Pharma's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nutra Pharma should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Nutra Pharma's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Nutra Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nutra Pharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nutra Pharma.
0.00
12/03/2025
No Change 0.00
0.0
In 3 months and 1 day
03/03/2026
0.00
If you would invest 0.00 in Nutra Pharma on December 3, 2025 and sell it all today you would earn a total of 0.00 from holding Nutra Pharma Corp or generate 0.0% return on investment in Nutra Pharma over 90 days. Nutra Pharma is related to or competes with Greater Cannabis. Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and tech... More
Nutra Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nutra Pharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nutra Pharma Corp upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nutra Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nutra Pharma's standard deviation. In reality, there are many statistical measures that can use Nutra Pharma historical prices to predict the future Nutra Pharma's volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Nutra Pharma. Your research has to be compared to or analyzed against Nutra Pharma's peers to derive any actionable benefits. When done correctly, Nutra Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Nutra Pharma Corp.
Nutra Pharma is out of control given 3 months investment horizon. Nutra Pharma Corp has Sharpe Ratio of 0.0941, which conveys that the firm had a 0.0941 % return per unit of risk over the last 3 months. We have analyze and collected data for twenty-five different technical indicators, which can help you to evaluate if expected returns of 4.7% are justified by taking the suggested risk. Use Nutra Pharma Corp Downside Deviation of 61.03, mean deviation of 20.88, and Risk Adjusted Performance of 0.1319 to evaluate company specific risk that cannot be diversified away. Nutra Pharma holds a performance score of 7 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -17.83, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Nutra Pharma are expected to decrease by larger amounts. On the other hand, during market turmoil, Nutra Pharma is expected to outperform it. Use Nutra Pharma Corp maximum drawdown and the relationship between the downside variance and day median price , to analyze future returns on Nutra Pharma Corp.
Auto-correlation
0.68
Good predictability
Nutra Pharma Corp has good predictability. Overlapping area represents the amount of predictability between Nutra Pharma time series from 3rd of December 2025 to 17th of January 2026 and 17th of January 2026 to 3rd of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nutra Pharma Corp price movement. The serial correlation of 0.68 indicates that around 68.0% of current Nutra Pharma price fluctuation can be explain by its past prices.
Correlation Coefficient
0.68
Spearman Rank Test
0.6
Residual Average
0.0
Price Variance
0.0
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in Nutra Pink Sheet
Nutra Pharma financial ratios help investors to determine whether Nutra Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nutra with respect to the benefits of owning Nutra Pharma security.